Table 2.
Number of Participants with Amino Acid Substitutions Occurring in ≥2 Participants at Baseline, n (%) a | ||
---|---|---|
Severe COVID-19 Study | Moderate COVID-19 Study | |
P323L | 50/53 (94%) | 8/9 (88%) |
A554V | 2/64 (3.1%) | 0/13 (0%) |
a The denominator is based on the number of participants with sequence coverage at the site of the substitution.